Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGSWW) Return on Invested Capital (2022 - 2025)

GeneDx Holdings has reported Return on Invested Capital over the past 4 years, most recently at 0.04% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.04% for Q4 2025, up 5.0% from a year ago — trailing twelve months through Dec 2025 was 0.04% (up 5.0% YoY), and the annual figure for FY2025 was 0.04%, up 5.0%.
  • Return on Invested Capital for Q4 2025 was 0.04% at GeneDx Holdings, down from 0.02% in the prior quarter.
  • Over the last five years, Return on Invested Capital for WGSWW hit a ceiling of 0.02% in Q3 2025 and a floor of 1.97% in Q1 2023.
  • Median Return on Invested Capital over the past 4 years was 0.53% (2024), compared with a mean of 0.68%.
  • Biggest five-year swings in Return on Invested Capital: tumbled -106bps in 2023 and later skyrocketed 148bps in 2024.
  • GeneDx Holdings' Return on Invested Capital stood at 1.47% in 2022, then soared by 51bps to 0.73% in 2023, then soared by 88bps to 0.09% in 2024, then surged by 59bps to 0.04% in 2025.
  • The last three reported values for Return on Invested Capital were 0.04% (Q4 2025), 0.02% (Q3 2025), and 0.02% (Q2 2025) per Business Quant data.